US$ 20.93
fda 503a bulks list bpc-157 category 2 1 vs. Category 2. The FDA's peptide update, explained. Category peptides are on the FDA's “difficult to compound” list, which effectively blocks licensed pharmacies from producing them. Category 1 means The peptide comeback narrative has
Description

Im super happy with this product

There is a theoretical --- though as yet unproven in humans --- risk that long-term or high-dose use could stimulate growth in existing malignant or pre-malignant cells

Always confirm deficiency through a blood test before committing to injections
